UPDATE: RBC Capital Starts Livongo Health Inc. (LVGO) at Outperform

(updating comment)

RBC Capital analyst Sean Dodge initiates coverage on Livongo Health Inc. (NASDAQ: LVGO) with a Outperform rating and a price target of $45.00.

The analyst comments "Livongo's data science-heavy approach to chronic condition management is helping address one of the more difficult and costly problems in healthcare. The TAM is immense and LVGO's effectiveness/differentiation is helping fuel significant revenue growth and what should be a very steep margin ramp, neither of which we believe are fully captured in its current valuation."

For an analyst ratings summary and ratings history on Livongo Health Inc. click here. For more ratings news on Livongo Health Inc. click here.

Shares of Livongo Health Inc. closed at $37.30 yesterday.

You May Also Be Interested In

• Berenberg Starts KSB SE & Co KGaA (KSB3:GR) at Buy
• RBC Capital Downgrades Var Energi (VAR:NO) to Sector Perform
• Guggenheim Starts Samsara Inc (IOT) at Buy